Kibo Energy Share Discussion Threads

[guitars4stars] 28/1/2021 14:18

We are so undervalued in my view!Good to see the back of the 0.20sWe will fly into the 0.40s in a blink, looking forward to late trades at close :)

[tomboyb] 28/1/2021 10:58

Edit -

5mill available at 0.33p -

[tomboyb] 28/1/2021 10:55

Spreadex were down to 2.8% on 14th Jan -

Let see if they have cleared as MMs moving price up a little -

[yaki] 28/1/2021 10:34

Nice 5m buy at 0.35p

Looks like not much selling at 0.3p
We need to flush out any short term traders (and who would say no 50% if they bought at 0.2p), before next leg up to 0.6p

[tomboyb] 28/1/2021 10:12

Looks like MMs want a drop below 0.30p again -

Lets do it -

[longshanks] 28/1/2021 09:50

Not sure that gives any answers georgeo1.The only advantage I can see is that it facilitates investors from territories excluded from investing on AIM. Is that the case here?

[johncasey] 28/1/2021 09:47

i think we will hit single figures soon

[johncasey] 28/1/2021 09:46

i wonder if the eua russian guy is buying some

[georgeo1] 28/1/2021 09:45

https://www.londonstockexchange.com/raise-finance/equity/compare-markets-listing-equity?lang=en&tab=listing

[mufprat] 28/1/2021 09:38

I'd be very surprised if any Institutions touch MED, assuming it floats, with a bargepole. Shares will be offloaded to PIs. In the same way that KAT was floated with a ridiculous Mkt Cap and became an instant short MED will follow the same path.Just my view of course, each to their own.

[longshanks] 28/1/2021 09:32

Excuse the ignorance, but why are they looking to float MED on the official list rather than AIM?At £20m market cap, it seems too small to justify this.

[guitars4stars] 28/1/2021 09:25

Great post Paddy & best with your investment!

[paddyfool] 28/1/2021 09:22

In the current climate it is highly likely that they will get the IPO away. money is chasing a home everywhere. the read across in value is therefore pretty clear. I believe that its highly likely that the will get this away at the pre money price of around £14 million which enables them to have a post money post float value of £20 million of which Kibo will own 55% therefore having attributable value of £11 million against a current market cap of £6-7 million. What happens after the shares are issued is anyones guess though the stock will be likely held by institutions meaning there won't be too much available. So it's not unreasonable to assume that post roadshow and float this will likely hold its value. That said then assuming that there is little of this in the price already then the upside from here is around 1.2-1.8 times. There is risk, minimal in my view , that this won't happen and the float may fail or a regulatory hurdle being failed. So apply an arbitrary discount to that say 50% and you end up a long way north of the current share price. If you start to take the pills and assume that demand for these new shares will be high then the number goes yet further north. So I've done the sums and I think KIBO is a great risk reward play in the near term and have therefore invested, for me reasonably heavily this morning. Each to their own path, and do your own research, I have!

[georgeo1] 28/1/2021 09:04

Plutus were well contracting for SSE.

[tomboyb] 28/1/2021 09:01

MMs opened up -

[lurker5] 28/1/2021 08:52

It not up to MAST to "approve" its prospectus.Its up to the London Stock Exchange. Before then any 'roadshow' will not be able to raise any funds. As for 'income' generation, that will have to go in the first place to whoever lends MED the funds for each generation site. £20m is only enough to cover the necessary equity component. And we still need to see how it is, miraculously, that Med will do better than Plutus Powergen - the late almost lamented and bust.

[edgein] 28/1/2021 08:47

Yaki,

It looks lucrative for sure:

"Following the LSE Admission of MED, MED and Sloane will be in a position to develop its portfolio at scale and pace, as opposed to a project-by-project basis and advance rapidly towards significant revenue generation. Upon successful completion of the IPO, Sloane will be in a position where it expects to have c.9MW in immediate production and c.20 MW in production within the first six months from listing and adding another c.20 MW in production over the next 6 months. The additional production capacity for the first c.20MW will come from Bordesley and 2nd acquisition sites, as well as the 3rd acquisition, announced on 28 October 2020. The capacity for the 2(nd) c.20MW is expected to come from a significant project pipeline, currently in an advanced stage of development".

That's 40MW within twelve months of listing and that previously announced that they expect their pipeline of projects to take them to 100MW. So lucrative indeed as the UK will need vastly more power to cover the EV demand.

Most folks don't seem to realise what's going on over at KAT too, Blyvoor is a company maker to them (measured and indicated plus future production). I'm expecting the value of KAT and therefore KIBO's circa 96m shares (25%) to increase dramatically over the next year regardless of the outcome of Haneti drilling. If Haneti does turn out to be world class as suggested in previous RNS releases then KIBO will re-rate all the more.

Regards,
Ed.

[mohammedalibusiness] 28/1/2021 08:43

As we rise up the riser board this will bring new eyes to the RNS, it is exceptional and actually life changing for shareholders.

[idriveajag] 28/1/2021 08:42

The next piece of the jigsaw is in place.

[tomboyb] 28/1/2021 08:40

Med alone is worth 11million to Kibo on IPO -

Cheap and Cheap v current cap -

[yaki] 28/1/2021 08:38

We should be 0.5p at least, on MED deal

[bean02] 28/1/2021 08:38

A break of .35 and it's anyone guess. Fresh territory

[tomboyb] 28/1/2021 08:37

Sum of all parts this is looking v cheap -

Will break 0.40p today -

[yaki] 28/1/2021 08:36

Ed, agreed
This MED deal looks way too lucrative. And is perfect timing with all the grid issues in the UK

[edgein] 28/1/2021 08:32

Yaki,

Yeah true then add in KAT and the CTPs and it'll be closer to the sum of all parts. Also as KIBO will remain majority shareholder of MED they could pay shareholders a dividend from their revenues after their production is established and therefore that's a revenue stream for KIBO.

Regards,
Ed.